“Can a Pilot Succeed?”: Lessons Learned in Engaging Stakeholders for HPV Introduction

In Madagascar, JSI supported the introduction of HPV vaccine in a two-phase pilot. Lora Shimp and Heather Casciato share the key lessons learned from the program for World Immunization Week.

Bright Light in HPV Vaccination Story: Traditionally Underserved Populations are Getting Attention

A recent report from the Centers for Disease Control and Prevention that most boys aren’t receiving the HPV vaccine is not surprising, but there is some exciting news lurking in the study’s finding: The boys who are more likely to receive the HPV vaccine are the traditionally underserved – those who are minority, Hispanic, lower income, or in a single-mother household.

JSI Expands Access to HPV Vaccine Internationally – and Improves Immunization Rates in our own Backyard

HPV affects millions and millions of people. HPV is the most common sexually transmitted infection, and an estimated 20 million people have the active virus at any time, according to WHO. While in the U.S., the HPV vaccine was licensed for girls in 2006, and for boys in 2009, in many other countries, the vaccine is only just being rolled out now. JSI’s Allison Hackbarth and Vanessa Richart describes efforts being made internationally in and in the U.S. to expand access to HPV vaccine.